Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | 1-Hydroxybenzotriazole hydrate | HCID 2796029 | — |
| Reactant | 2-Chloro-3-(trifluoromethyl)benzylamine | HCID 5224207 | — |
| Reactant | 1-Methyl-2-oxoimidazolidine-4-carboxylic acid | HCID 13852999 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 59252117 | HCID 59252117 | 55% |
Reaction Steps
A mixture of 1-methyl-2-oxo-4-imidazolidinecarboxylic acid (144 mg, 1 mmol), N-ethyl morpholine (0.767 ml, 6.00 mmol), 1-hydroxybenzotriazole hydrate (184 mg, 1.200 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (230 mg, 1.200 mmol) in dichloromethane (18 ml) was stirred at room temperature for 10 minutes. A solution of {[2-chloro-3-(trifluoromethyl)phenyl]methyl}amine (210 mg, 1.000 mmol) in dichloromethane (2 ml) was added and the reaction stirred at room temperature for hours. The mixture was diluted with dichloromethane and the mixture was washed with 3N citric acid solution. The organic phase was separated, washed with brine, dried and evaporated. The residue was purified by mass-directed automated HPLC to give the N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-2-oxo-4-imidazolidinecarboxamide (150 mg, 55%). LC/MS [M+H]+=336, retention time=2.22 minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07932282B2 |
|---|
| Source dataset | uspto-grants-2011_04 |
|---|
| ORD ID | ord-c39e31b1de224a428f9837d4eff9715b |
|---|
| Source note | uspto-grants-2011_04 |
|---|